Malignant hypertension has a 5-year survival of 74% with modern therapy, though black patients have a worse prognosis due to late presentation and renal impairment.
Malignant hypertension remains a disease with a poor overall prognosis, namely progression to death or chronic renal haemodialysis. The prognosis has improved with recent advances in therapy, with a 5-year survival of 74% of patients. The poor outlook for black patients could be explained by their late presentation with severe hypertension and the higher prevalence of renal impairment in this group.
Lip et al. (Tue,) studied this question.